466 related articles for article (PubMed ID: 23084789)
1. The use of dehydroepiandrosterone in the treatment of hypoactive sexual desire disorder: a report of gender differences.
Bloch M; Meiboom H; Zaig I; Schreiber S; Abramov L
Eur Neuropsychopharmacol; 2013 Aug; 23(8):910-8. PubMed ID: 23084789
[TBL] [Abstract][Full Text] [Related]
2. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women.
Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
Menopause; 2009; 16(5):923-31. PubMed ID: 19424093
[TBL] [Abstract][Full Text] [Related]
3. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of oral DHEA treatment for sexual function, well-being, and menopausal symptoms in postmenopausal women with low libido.
Panjari M; Bell RJ; Jane F; Wolfe R; Adams J; Morrow C; Davis SR
J Sex Med; 2009 Sep; 6(9):2579-90. PubMed ID: 19619146
[TBL] [Abstract][Full Text] [Related]
5. Effects of transdermal testosterone or oral dydrogesterone on hypoactive sexual desire disorder in transsexual women: results of a pilot study.
Kronawitter D; Gooren LJ; Zollver H; Oppelt PG; Beckmann MW; Dittrich R; Mueller A
Eur J Endocrinol; 2009 Aug; 161(2):363-8. PubMed ID: 19497984
[TBL] [Abstract][Full Text] [Related]
6. Women with low libido: correlation of decreased androgen levels with female sexual function index.
Turna B; Apaydin E; Semerci B; Altay B; Cikili N; Nazli O
Int J Impot Res; 2005; 17(2):148-53. PubMed ID: 15592425
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Tribulus Terrestris for the treatment of premenopausal women with hypoactive sexual desire disorder: a randomized double-blinded, placebo-controlled trial.
Vale FBC; Zanolla Dias de Souza K; Rezende CR; Geber S
Gynecol Endocrinol; 2018 May; 34(5):442-445. PubMed ID: 29172782
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Tribulus terrestris for the treatment of hypoactive sexual desire disorder in postmenopausal women: a randomized, double-blinded, placebo-controlled trial.
de Souza KZ; Vale FB; Geber S
Menopause; 2016 Nov; 23(11):1252-1256. PubMed ID: 27760089
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
Braunstein GD; Sundwall DA; Katz M; Shifren JL; Buster JE; Simon JA; Bachman G; Aguirre OA; Lucas JD; Rodenberg C; Buch A; Watts NB
Arch Intern Med; 2005 Jul; 165(14):1582-9. PubMed ID: 16043675
[TBL] [Abstract][Full Text] [Related]
10. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
Krapf JM; Simon JA
Maturitas; 2009 Jul; 63(3):213-9. PubMed ID: 19487090
[TBL] [Abstract][Full Text] [Related]
11. Sexual desire, sexual arousal and hormonal differences in premenopausal US and Dutch women with and without low sexual desire.
Heiman JR; Rupp H; Janssen E; Newhouse SK; Brauer M; Laan E
Horm Behav; 2011 May; 59(5):772-9. PubMed ID: 21514299
[TBL] [Abstract][Full Text] [Related]
12. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study.
Shifren JL; Davis SR; Moreau M; Waldbaum A; Bouchard C; DeRogatis L; Derzko C; Bearnson P; Kakos N; O'Neill S; Levine S; Wekselman K; Buch A; Rodenberg C; Kroll R
Menopause; 2006; 13(5):770-9. PubMed ID: 16932240
[TBL] [Abstract][Full Text] [Related]
13. Maintaining physiologic testosterone levels during combined oral contraceptives by adding dehydroepiandrosterone: II. Effects on sexual function. A phase II randomized, double-blind, placebo-controlled study.
van Lunsen RHW; Zimmerman Y; Coelingh Bennink HJT; Termeer HMM; Appels N; Fauser BCJM; Laan E
Contraception; 2018 Jul; 98(1):56-62. PubMed ID: 29490289
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
Davis SR; van der Mooren MJ; van Lunsen RH; Lopes P; Ribot C; Rees M; Moufarege A; Rodenberg C; Buch A; Purdie DW
Menopause; 2006; 13(3):387-96. PubMed ID: 16735935
[TBL] [Abstract][Full Text] [Related]
15. Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens.
Arlt W; Haas J; Callies F; Reincke M; Hübler D; Oettel M; Ernst M; Schulte HM; Allolio B
J Clin Endocrinol Metab; 1999 Jun; 84(6):2170-6. PubMed ID: 10372727
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study.
Berman JR; Berman LA; Toler SM; Gill J; Haughie S;
J Urol; 2003 Dec; 170(6 Pt 1):2333-8. PubMed ID: 14634409
[TBL] [Abstract][Full Text] [Related]
17. Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal women.
Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Gilbert L; Martel C; Balser J
J Sex Med; 2014 Jul; 11(7):1766-85. PubMed ID: 24774442
[TBL] [Abstract][Full Text] [Related]
18. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial.
Hunt PJ; Gurnell EM; Huppert FA; Richards C; Prevost AT; Wass JA; Herbert J; Chatterjee VK
J Clin Endocrinol Metab; 2000 Dec; 85(12):4650-6. PubMed ID: 11134123
[TBL] [Abstract][Full Text] [Related]
19. Androgen replacement therapy with dehydroepiandrosterone for androgen insufficiency and female sexual dysfunction: androgen and questionnaire results.
Munarriz R; Talakoub L; Flaherty E; Gioia M; Hoag L; Kim NN; Traish A; Goldstein I; Guay A; Spark R
J Sex Marital Ther; 2002; 28 Suppl 1():165-73. PubMed ID: 11898698
[TBL] [Abstract][Full Text] [Related]
20. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men.
Wolf OT; Neumann O; Hellhammer DH; Geiben AC; Strasburger CJ; Dressendörfer RA; Pirke KM; Kirschbaum C
J Clin Endocrinol Metab; 1997 Jul; 82(7):2363-7. PubMed ID: 9215320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
